1. bookVolume 24 (2016): Issue 3 (September 2016)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Chronic myelomonocytic leukemia “myelodysplastic type’’ in transformation to acute myeloid leukemia – diagnostic and therapeutic options: case report and literature review / Leucemie mielomonocitară cronică forma mielodisplazică în transformare spre leucemie acută mieloidă – diagnostic și opțiuni terapeutice: prezentare de caz și revizuirea literaturii

Published Online: 15 Oct 2016
Page range: 263 - 277
Received: 28 Jul 2016
Accepted: 12 Sep 2016
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that is characterized by the presence of an absolute monocytosis (1 × 10^ 9/l) in the peripheral blood, the overlap of myelodisplastic aspects and myeloproliferative aspects in the bone marrow and tendency to transform into acute myeloid leukemia. CMML is considered to be the most aggressive chronic myeloid leukemia. We present the case of a 48 years old woman who was hospitalized in March 2013 in the Center of Hematology and Bone Marrow Transplantation for anemia related symptoms. Initial investigations showed anemia, relative monocytosis (10% monocytes of the WBC differential) with an increasing absolute number of monocytes (> 1,000/μl) in the following months. Initial exploration of the bone marrow (aspirate and bone marrow biopsy and immunohistochemistry IHC tests) revealed elements of trilinear dysplasia and an increased percentage of myeloblasts (11-14%). In the next four months myeloblasts percentage remained below 20% (8-14%) and it has been observed a gradually increasing of monocytoid elements (> 20%). Immunophenotyping in the bone marrow aspirate identified a monocytic proliferation with high percentage (8%) of immature cells. The karyotype reported the presence of clones with t (1;3). Initially diagnosed as RAEB-2 (WHO) the case was recomitted in CMML-type 2 with a progression to acute myeloid leukemia (AML). Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been performed after getting the best possible therapeutic response with AML chemotherapy type (complete remission). Allo-HSCT was performed using myeloablative conditioning, 12 months after diagnosis. The patient is now in complete remission, 24 months after allo-HSCT.

Keywords

1. Orazi A, Bennett JM, Germing U, Brunning RD, Bain BJ, Thicle J. Chronic myelomonocytic leukaemia, Swerdlow S, Campos E, Lee Harris NL, Jaffe ES, Stefano PA, Stein H, et al, editors. WHO Classification of tumours of haematopoietic and lymphoid tissues: Lyon, France: International Agency for Research on Cancer. 2008:74-79.Search in Google Scholar

2. Vardiman JW, Thile J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul;114(5):937-51.DOI: 10.1182/blood-2009-03-209262.10.1182/blood-2009-03-20926219357394Search in Google Scholar

3. Bennett JM, Catovsky O, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 June;51(2):189-99. DOI: 10.1111/ j.1365-2141.1982.tb08475.x.10.1111/j.1365-2141.1982.tb08475.xSearch in Google Scholar

4. Arber DA, Orazi A, Hasserjan R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May;127(20):2391-2405. DOI: 10.1182/blood-2016-03-643544.10.1182/blood-2016-03-64354427069254Search in Google Scholar

5. Such E, Cervera J, Costa D, Sole F, Vallespi T, Luno E, et al. Cytogenetic stratification in chronic myelomonocytic leukemia. Haematologica. 2011 Mar;96(3):375-383. DOI: 10.3324/haematol.2010.03095710.3324/haematol.2010.030957304626821109693Search in Google Scholar

6. Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C, et al. Clonal architecture of chronic myelomonocytic leukemia. Blood. 2013 Mar;121(12):2186-98. DOI: 10.1182/ blood-2012-06-440347.10.1182/blood-2012-06-44034723319568Search in Google Scholar

7. Mughal TI, Cross NCP, Padron E, Tiu RV, Savona M, Malcovati L. An International MDS/ MPN Working Group’s Perspective and Recommendations on Molecular Pathogenesis, Diagnosis and Clinical Characterization of Myelodysplastic/ myeloproliferative Neoplasm. Haematologica. 2015 Sep;100(9):1117-30. DOI: 10.3324/haematol.2014.114660.10.3324/haematol.2014.114660480069926341525Search in Google Scholar

8. Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008 Jul;112(1):45-52. DOI: 10.1182/blood-2008-01-134858.10.1182/blood-2008-01-13485818443215Search in Google Scholar

9. Gologan R, Berceanu A, Colita A, Codreanu V, Dobrea C, Geoada L, et al. Clinical and Hematological Aspects of Chronic Myelomonocytic Leukemia. Study on 20 cases from a single center from Romania. Rom J Intern Med. 2002;40(1-4):95-102.Search in Google Scholar

10. Patiu M, Plesa A, Cucuianu A. Chronic myelomonocytic leukemia. A comparative study of the subtype: dysplasia and proliferative. Documenta Haematologica. 2000;5:63-68.Search in Google Scholar

11. Colita A, Colita D, Gologan R. A single Center retrospective analysis of 42 cases of chronic myelomonocytic leukemia – poster presentation: Paris, France: The 7th International Meeting on MDS.2003.Search in Google Scholar

12. Wang Sa A, Galili N, Cerny J, Sechman E, Chen SS, Loew J, et al. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. An J. Clin. Pathol. 2006 Nov;126(5):789-97. DOI: 10.1309/ FU04P779U310R3EE.10.1309/FU04P779U310R3EESearch in Google Scholar

13. Patnaik MM, Padron E, LaBorde RR, Lasho TL, Finke CM, Hanson CA, et al. Mayo prognostic model for WHO – defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia. 2013 Jul;27(7):1504-10. DOI: 10.1038/leu.2013.88.10.1038/leu.2013.8823531518Search in Google Scholar

14. Germing U, Strupp C, Knipp S, Kuendgen A, Giagounidis A, Hildebrandt B, et al. Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica. 2007 Jul;92:974-7. DOI: 10.3324/haematol. 11051.Search in Google Scholar

15. Schuler E, Schroeder M, Neukirchen J, Strupp C, Xicoy B, Kundgen A, et al. Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias. Leukemia Research. 2014 Sep;38:1413-19. DOI: 10.1016/j.leukres.2014.09.003. 10.1016/j.leukres.2014.09.00325444076Search in Google Scholar

16. Onida F, Baroni G, Leone G, Malcovati L, Morra E, Santini V, et al. Management recommendations for chronic myelomonocytic leukemia: conseum statements from the SIE, SIES, GITMO groups. Haematologica. 2013 Sep;98(9):1344-52. DOI: 10.3324/haematol.2013.084020. 10.3324/haematol.2013.084020376208924006407Search in Google Scholar

17. Such E, Germing U, Malcovati L, Cervera J, Kuengen A, Porta MGD, et al. Development and validation of a prognostic scoring system for patients. Blood. 2013 Apr;121(15):3005-15. DOI: 10.1182/ blood-2012-08-452938.10.1182/blood-2012-08-45293823372164Search in Google Scholar

18. Calvo X, Nomdedeu M, Santacruz R, Martinez N, Costa D, Pereira A, et al. Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML- specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML. Leukemia Research. 2015 Jul;39:1146-53. DOI: 10.1016/j.leukres.2015.05.017.10.1016/j.leukres.2015.05.01726354683Search in Google Scholar

19. Shaffer LG, McGowan-Jordan J, Schmid M. ISCN 2013: An International System for Human Cytogenetic Nomenclature (2013): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel, Switzerland: 2013: 78-79.Search in Google Scholar

20. Kekre N, Ho VT. Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia. Am J Hematol. 2015 Nov;91(1):123-30. DOI: 10.1002/ajh.24215.10.1002/ajh.2421526453238Search in Google Scholar

21. Symeonidis A, van Biezen A, de Wreede L, Piciocchi A, Finke J, Beelen D, et al. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the chronic malignancies working party of the European group for blood and marrow transplantation. Br J Haematol. 2015 Jul;171(2):239-46. DOI: 10.1111/bjh.13576.10.1111/bjh.1357626212516Search in Google Scholar

22. Duong Hk, Akhtari M, Ahn KW, Hu ZH, Popat UR, Alyea III EP, et al. Allogeneic hematopoietic cell transplantation for adult chronic myelomonocytic leukemia. Bio Blood Marrow Transplant. 2015 Feb;21(2):S30-S31. DOI: 10.1016/j.bbmt.2014.11.022.10.1016/j.bbmt.2014.11.022Search in Google Scholar

23. Kongtim P, Popat U, Jimenez A, Gaballa S, Fakih RE, Rondon G, et al. Treatment with hypomethylating agents before allogeneic stem cell transplant improves progression free survival for patients with chronic myelomonocytic leukemia. Bio Blood Marrow Transplant. 2016 Jan;22(1):47-53. DOI: 10.1016/j.bbmt.2015.08.031.10.1016/j.bbmt.2015.08.031489236426343946Search in Google Scholar

24. Sharma P, Shinde S, Patnaik M. Outcomes of allogeneic stem cell transplant in patients with chronic myelomonocytic leukemia (CMML) – A single institution experience. Biol Blood Marrow Transplant. 2015 Feb; 21(2):S193-S194. DOI: 10.1016/j.bbmt.2014.11.293. 10.1016/j.bbmt.2014.11.293Search in Google Scholar

25. Park S, Labopin M, Agha IY, Delaunay J, Dhedin N, Deconinck E, et al. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: A report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Eur J Haematol. 2013 May;90(5):355-64. DOI: 10.1111/ejh.12073.10.1111/ejh.1207323320648Search in Google Scholar

26. Eissa H, Gooley TA, Sorror ML, Nguyen F, Scott BL, Doney K et al – Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: Relapse- free survival is determined by karyotype and comorbidities. Bio Blood Marrow Transplant. 2011 Jun;17(6):908-15. DOI: 10.1016/j.bbmt.2010.09.018.10.1016/j.bbmt.2010.09.018310043220932924Search in Google Scholar

27. Krishnamurthy P, Lim Zy, Nagi W, Kenyon M, Mijovic A, Ireland R -Allogeneic haematopoietic SCT for chronic myelomonocytic leukemia: A single- centre experience. Bone Marrow Transplant. 2010 Jan;45:1502-7. DOI: 10.1038/bmt.2009.375.10.1038/bmt.2009.37520098454Search in Google Scholar

28. Ocheni S, Kroger N, Zabelina T, Zander AR, Bacher U. Outcome of allo-SCT for chronic myelomonocytic leukemia. Bone Marrow Transplant. 2009 Apr;43(8):659-61. DOI: 10.1038/bmt.2008.366.10.1038/bmt.2008.36618997830Search in Google Scholar

29. Elliott MA, Tefferi A, Hogan WJ, Letendre L, Gastineau DA, Ansell SM, et al. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplant. 2006 Jun;37(11):1003-8. DOI: 10.1038/sj.bmt.1705369. 10.1038/sj.bmt.170536916604096Search in Google Scholar

30. Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM, et al. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia. Biol Blood Marrow Transplant. 2005 Sep;11(9):713-20. DOI: 10.1016/j.bbmt.2005.05.00810.1016/j.bbmt.2005.05.00816125642Search in Google Scholar

31. Kroger N, Zabelina T, Guardiola P, Runde V, Sierra J, Van Biezen A, et al. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukemia: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Tranplantation (EBMT). Br. J Haematol. 2002 Jul;118(1):67-73. DOI: 10.1046/j.1365-2141.2002.03552.x.10.1046/j.1365-2141.2002.03552.x12100129Search in Google Scholar

32. Cheng H, Kirtani VG, Gergis U. Current status of allogeneic HST for chronic myelomonocytic leukemia. Bone Marrow Transplantation. 2012 Apr;47(4):535-41. DOI: 10.1038/bmt.2011.141.10.1038/bmt.2011.14121743499Search in Google Scholar

33. Patnaik MM, Parikh SA, Hanson CA, Tefferi A. Chronic myelomonocytic leukaemia: a concise clinical and pathophsysiological review. Br J Haematol. 2014 May;165(3):273-86. DOI: 10.1111/bjh.12756. 10.1111/bjh.1275624467717Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo